Scherzer-Attali, R <br/><br/>
Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.  [electronic resource] 

 -  Neurobiology of disease  Jun 2012 
 - 663-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-953X 
<br/><br/><label>Standard No.: </label>10.1016/j.nbd.2012.03.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--drug therapy<br/>Amyloid beta-Peptides--antagonists & inhibitors<br/>Animals<br/>Animals, Genetically Modified<br/>Benzothiazoles<br/>Blood-Brain Barrier--metabolism<br/>Brain Chemistry--drug effects<br/>Cognition--drug effects<br/>Drosophila--metabolism<br/>Fluorescent Dyes<br/>Humans<br/>Longevity--drug effects<br/>Magnetic Resonance Spectroscopy<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Microscopy, Electron, Transmission<br/>Models, Molecular<br/>Motor Activity--drug effects<br/>Naphthalenes--pharmacology<br/>Neurofibrils--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Psychomotor Performance--drug effects<br/>Recognition, Psychology--drug effects<br/>Thiazoles<br/>Tryptophan--analogs & derivatives